Acknowledgement to Referees
- PDF / 340,820 Bytes
- 4 Pages / 595.276 x 790.866 pts Page_size
- 6 Downloads / 174 Views
ACKNOWLEDGEMENT
Acknowledgement to Referees
© Springer Nature Switzerland AG 2020
Dear Reader, Welcome to the final issue of Clinical Drug Investigation for 2020. This year has presented many challenges and I would like to take this opportunity to thank all who have contributed to ensuring the journal has thrived despite the extraordinary circumstances that the science community, and the world in general, has faced. The COVID-19 pandemic has reinforced the importance of rapid and wide dissemination of high-quality information. Springer Nature is supporting the global response to COVID-19 by making all relevant content immediately and freely available. Indeed, Clinical Drug Investigation has published a number of papers relevant to the COVID-19 pandemic that are free to access. I would like to start by thanking the authors of the articles published in Clinical Drug Investigation over the course of 2020. The enthusiasm of all authors for their chosen fields and their willingness to contribute content to the journal are crucial for its continued success. 2020 was a successful year for Clinical Drug Investigation. Over 115 articles have been published; the most popular of these, in terms of downloads from SpringerLink, have been: Zhang, S., Li, L., Shen, A. et al. Rational Use of Tocilizumab in the Treatment of Novel Coronavirus Pneumonia. Clin Drug Investig 40, 511–518 (2020). https://doi.org/10.1007/s40261-020-00917-3 Das, S., Bhowmick, S., Tiwari, S. et al. An Updated Systematic Review of the Therapeutic Role of Hydroxychloroquine in Coronavirus Disease-19 (COVID-19). Clin Drug Investig 40, 591–601 (2020). https://doi.org/10.1007/s40261-020-00927-1 Bleyzac, N., Goutelle, S., Bourguignon, L. et al. Azithromycin for COVID-19: More Than Just an Antimicrobial?. Clin Drug Investig 40, 683–686 (2020). https://doi.org/10.1007/s40261-020-00933-3 Ayad, S., Demitrack, M.A., Burt, D.A. et al. Evaluating the Incidence of Opioid-Induced Respiratory Depression Associated with Oliceridine and Morphine as Measured by the Frequency and Average Cumulative Duration of Dosing Interruption in Patients Treated for Acute Postoperative Pain. Clin Drug Investig 40, 755–764 (2020). https://doi.org/10.1007/s4026 1-020-00936-0 Martínez-Cuadrón, D., Rodríguez-Macías, G., Rodríguez-Veiga, R. et al. Practical Considerations for Treatment of Relapsed/ Refractory FLT3-ITD Acute Myeloid Leukaemia with Quizartinib: Illustrative Case Reports. Clin Drug Investig 40, 227–235 (2020). https://doi.org/10.1007/s40261-019-00881-7 The quality of articles published in the journal is also reflected in its most recent impact factor (2019 impact factor 2.267).
Vol.:(0123456789)
1094
Acknowledgement to Referees
The quality of published articles is also testament to the significant efforts of the peer reviewers, whose willingness to share their expertise ensures that the journal’s content is held to the highest possible standard. We would like to thank the following individuals who acted as reviewers for Clinical Drug Investigation in the last
Data Loading...
